Heterocyclic Compounds, 2-Ring
"Heterocyclic Compounds, 2-Ring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of organic compounds containing two ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.
Below are MeSH descriptors whose meaning is more general than "Heterocyclic Compounds, 2-Ring".
Below are MeSH descriptors whose meaning is more specific than "Heterocyclic Compounds, 2-Ring".
This graph shows the total number of publications written about "Heterocyclic Compounds, 2-Ring" by people in Harvard Catalyst Profiles by year, and whether "Heterocyclic Compounds, 2-Ring" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 0 | 3 |
| 2015 | 3 | 0 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 3 | 1 | 4 |
Below are the most recent publications written about "Heterocyclic Compounds, 2-Ring" by people in Profiles.
-
ß-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell. 2020 12 10; 183(6):1520-1535.e14.
-
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial. JAMA. 2020 10 20; 324(15):1512-1521.
-
Vericiguat in Heart Failure with Reduced Ejection Fraction. N Engl J Med. 2020 10 08; 383(15):1497.
-
Vericiguat in Heart Failure With Reduced Ejection Fraction With High Natriuretic Peptides: A Case of Too Little, Too Late? JACC Heart Fail. 2020 11; 8(11):940-942.
-
Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1. Exp Hematol. 2019 06; 74:42-51.e3.
-
Rationale and Design of the VITALITY-HFpEF Trial. Circ Heart Fail. 2019 05; 12(5):e005998.
-
Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study. Oncologist. 2019 08; 24(8):e740-e748.
-
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study. Eur J Heart Fail. 2017 06; 19(6):782-791.
-
Potential of synthetic endoperoxides against Trichomonas vaginalis in vitro. Parasitol Int. 2017 Oct; 66(5):619-621.
-
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017 04 14; 38(15):1119-1127.